Cargando…
Hyperkalemia in patients treated with endoradiotherapy combined with amino acid infusion is associated with severe metabolic acidosis
BACKGROUND: Amino acid co-infusion for renal protection in endoradiotherapy (ERT) applied as prostate-specific membrane antigen (PSMA)-targeted radioligand therapy (RLT) or peptide receptor radionuclide therapy (PRRT) has been shown to cause severe hyperkalemia. The pathophysiology behind the rapid...
Autores principales: | Pfob, Christian H., Eiber, Matthias, Luppa, Peter, Maurer, Florian, Maurer, Tobias, Tauber, Robert, D’Alessandria, Calogero, Feuerecker, Benedikt, Scheidhauer, Klemens, Ott, Armin, Heemann, Uwe, Schwaiger, Markus, Schmaderer, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829280/ https://www.ncbi.nlm.nih.gov/pubmed/29488080 http://dx.doi.org/10.1186/s13550-018-0370-z |
Ejemplares similares
-
Synthesis and Preclinical Evaluation of (177)Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer
por: Wurzer, Alexander, et al.
Publicado: (2022) -
Synthesis and preclinical evaluation of DOTAGA-conjugated PSMA ligands for functional imaging and endoradiotherapy of prostate cancer
por: Weineisen, Martina, et al.
Publicado: (2014) -
Radiolabelled Peptides for Positron Emission Tomography and Endoradiotherapy in Oncology †
por: Rangger, Christine, et al.
Publicado: (2020) -
Promise and challenges of clinical non-invasive T-cell tracking in the era of cancer immunotherapy
por: Gosmann, Dario, et al.
Publicado: (2022) -
Pharmaceuticals—Special Issue on Radiopharmaceutical Chemistry between Imaging and Endoradiotherapy
por: Kopka, Klaus
Publicado: (2014)